// App-Quantinova.ai

AB1456 (2022) : CLINICAL IMPACT OF THE INTERSTITIAL LUNG DISEASE MULTIDISCIPLINARY SERVICE

Researchers

Presenter

  • S. Eisa

Principal Investigators

  • B. Osei-Boadu

  • G. Singh-Rathore

  • M. Rabbani

  • K. Suthar

  • S. Ansari

  • G. M. Koduri

Medical Centers

  • Southend University Hospital, Essex, United Kingdom

  • Southend UniversityHospital Mid and SouthEssex NHS Foundation Trust, Rheumatology, Souhend, United Kingdom

  • Southend University Hospital, Essex, United Kingdom

  • Southend University Hospital, Essex, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Interstitial lung disease

Biomarkers

  • Pore forming protein

Drug/Treatment

  • Pirfenidone

  • Nintedanib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved